Log In
BCIQ
Print this Print this
 

recAP (recombinant alkaline phosphatase) subcutaneous

  Manage Alerts
Collapse Summary General Information
Company AM-Pharma B.V.
DescriptionSubcutaneous formulation of recAP (recombinant Alkaline Phosphatase)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Metabolic (unspecified)
Indication Details Treat severe hypophosphatasia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today